ArticleMolecular therapy oncolytics2021

Combined BRM270 and endostatin inhibit relapse of NSCLC while suppressing lung cancer stem cell proliferation induced by endostatin.

Yan-Hui Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.